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A response to and comment on Practical methods for incorporating summary time-to-event data into meta-analysis,
by Jayne F Tierney et al.Findings
As stated in the present article [1] by Tierney and
colleagues, time-to-event outcomes were most appropriately
analyzed using hazard ratios in meta-analyses. It provided
step-by-step guidance on how to calculate hazard ratios and
the associated statistics for individual trials, according to the
information presented in the trial report. Among the 11
methods stated in this article, one of them presented
suggested that, if it was reported in terms of P-value
and events in each arm (and the randomization ratio
was 1:1), these data can be used to estimate the O-E
using Tierney’s equation 14:
O−E ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Observed events research Observed events controlp
Total observed events
 z score for P value  2ð Þ
In the example of the present article, the log-rank
P-value of 0.075 gave a z-score of 1.78 according to
the latter part of Tierney’s equation 14. Nevertheless,
we found 2-sided P-value of 0.075 gave a z-score of
1.78 by using the net tools [2]. But the z-score for the
2-sided P-value should be divided by 2 as described
by Tierney and colleagues. Thus we can speculate
that the z-score for a P-value of 0.075 should be 0.89,
which was produced from 1.78/2.
We also advertently found that a right-tailed P-value
of 0.0375 gave a z-score of 1.78 by using the previous
mentioned net tools [2], and 0.0375 by chance equals* Correspondence: bettyzeng@foxmail.com
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distribution, and reproduction in any medium0.075/2. So we speculated that the latter part of equation
14 required a more accurate representation of z-score
and P-value as: z-score for (P-value/2).
Tierney and colleagues reported that if a 1-sided
P-value was reported, it can be used directly to calculate
the z-score without dividing by 2. According to Li [3], a
1-sided P-value was used in log-rank test or Cox regression,
and the exact P-value was given in the table for Chi-square
(right-tailed test). However, we verified that a right-tailed
P-value 0.075 gave a z-score of 1.44 by using the previous
mentioned net tools [2].
Therefore, we can conclude that a 2-sided P-value can be
used to directly to obtain the z-score. The latter part of
equation 14 need to be modified into: z-score for P-value.
Otherwise, a 1-sided P-value divided by 2 is required to
obtain the z-score and the latter part of equation 14 should
be expressed more exactly as: z-score for (P-value/2).
Authors’ reply
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, Sarah
Burdett and Matthew R Sydes.
We thank the correspondents for bringing to our
attention the unfortunate ambiguity in our article [1]. It
is correct that the P-value that should be divided by 2 in
equation 14 and not the z-score. This was the intention,
and is more explicit in the original equation [4], provided
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be more precisely stated as:
O−E ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Observed events research  Observed events control
Total observed events
r
 z−score for p 2ð Þ
and the related explanatory text altered accordingly: “As
well as the events on each arm and overall, the z-score for
half the two-sided P-value is required”
However, we disagree with the other points raised. It is
suggested that one-sided P-values are used in log-rank
tests and Cox regression models [3], whereas we find that it
is standard practice to present two-sided (or two-tailed)
P-values. Also, to our knowledge, all major statistical
packages output two-sided P-values by default. It is
therefore reasonable to assume that a P-value quoted
in a trial publication will be two-sided unless otherwise
stated, and to use this in equation 14. However, as
described in the text [1]: “If a one-sided P-value is reported
it can be used directly to obtain the z-score.”
This is justified by equation 14 being derived algebraically
from the definition of the log-rank statistic as a normally-
distributed random variable, and by the fact that a
one-sided P-value (assuming the most extreme direction
of effect) is half the magnitude of the corresponding
two-sided P-value.
The correspondents go on to suggest that either a
two-sided P-value or a one-sided P-value divided by 2
can be used directly in equation 14. In fact, this would
produce an incorrect z-score and hazard ratio. Using the
example in Tierney and colleagues, the z-score for the
reported P-value of 0.075/2 (= 0.0375) is 1.78, as the
correspondents themselves found using internet tools.
This produces an O-E of 19.57 and hazard ratio of 0.85; the
latter being identical to that reported in the trial publication
[5]. If, as the correspondents suggested, we had used the
reported P-value directly in equation 14, we would have
obtained a z-score of 1.44, O-E of 15.82 and an incorrect
hazard ratio of 0.88.
Finally, researchers wishing to estimate hazard ratios
from published time-to-event data need not rely on
deriving them manually using the equations provided
[1], but instead can use the Excel spreadsheet that
accompanies the paper. Moreover, they can use this to
cross-check hazard ratios derived from different methods
of estimation.
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